BRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase

Reuters07-23

July 23 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O:

ORAMED PHARMACEUTICALS INC - ENTERS OPTION AGREEMENT WITH SCILEX FOR WARRANT REPURCHASE - SEC FILING
ORAMED PHARMACEUTICALS INC - REPURCHASE OF WARRANTS FOR $27 MILLION IN TWO TRANCHES - SEC FILING

Source text: [ID:n0001213900-25-066819]

Further company coverage: ORMP.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2553248926?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 20:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553248926","market":"us","top_or_hot":-1,"title":"BRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase </title></head><body><p><span>July 23 (Reuters)</span><span> - </span>Oramed Pharmaceuticals Inc <span>ORMP.O</span>:</p><ul><li><p>ORAMED PHARMACEUTICALS INC - ENTERS OPTION AGREEMENT WITH SCILEX FOR WARRANT REPURCHASE - SEC FILING</p></li><li><p>ORAMED PHARMACEUTICALS INC - REPURCHASE OF WARRANTS FOR $27 MILLION IN TWO TRANCHES - SEC FILING</p></li></ul><p>Source text: [ID:n0001213900-25-066819]</p><p>Further company coverage: <span>ORMP.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-23 20:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase </title></head><body><p><span>July 23 (Reuters)</span><span> - </span>Oramed Pharmaceuticals Inc <span>ORMP.O</span>:</p><ul><li><p>ORAMED PHARMACEUTICALS INC - ENTERS OPTION AGREEMENT WITH SCILEX FOR WARRANT REPURCHASE - SEC FILING</p></li><li><p>ORAMED PHARMACEUTICALS INC - REPURCHASE OF WARRANTS FOR $27 MILLION IN TWO TRANCHES - SEC FILING</p></li></ul><p>Source text: [ID:n0001213900-25-066819]</p><p>Further company coverage: <span>ORMP.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nFWN3TK16R:1","article_id":"2553248926","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553248926","pubTimestamp":1753274342,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase July 23  - Oramed Pharmaceuticals Inc ORMP.O:ORAMED PHARMACEUTICALS INC - ENTERS OPTION AGREEMENT WITH SCILEX FOR WARRANT REPURCHASE - SEC FILINGORAMED PHARMACEUTICALS INC - REPURCHASE OF WARRANTS FOR $27 MILLION IN TWO TRANCHES - SEC FILINGSource text: [ID:n0001213900-25-066819]Further company coverage: ORMP.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ORMP":"Oramed Pharmaceuticals Inc."},"translate_title":"简介-Oramed Pharmaceuticals与Scilex签订认股权证回购期权协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORMP":0.9},"content_text":"BRIEF-Oramed Pharmaceuticals Enters Option Agreement With Scilex For Warrant Repurchase July 23 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O:ORAMED PHARMACEUTICALS INC - ENTERS OPTION AGREEMENT WITH SCILEX FOR WARRANT REPURCHASE - SEC FILINGORAMED PHARMACEUTICALS INC - REPURCHASE OF WARRANTS FOR $27 MILLION IN TWO TRANCHES - SEC FILINGSource text: [ID:n0001213900-25-066819]Further company coverage: ORMP.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2553248926","isCrawlerRequest":true}